Medical Director- Oncology Treatment Experience, Insights & Education

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

Purpose

The Treatment Experience, Insights and Education group within Global Medical Affairs, Oncology aims to reduce barriers to physician acceptance of oncology therapies and appropriate patient care by identifying and addressing educational gaps related to toxicity mitigation and management guidance.  The Medical Director provides specialist medical and scientific expertise in common toxicities associated with emerging oncology therapies to provide input into core medical affairs activities including health-care professional and provider interactions; generation of clinical and scientific data; educational initiatives and safeguarding patient safety.   Works closely with Medical Affairs Therapeutic Area (TA) teams and cross-functional R&D colleagues across product lifecycles to facilitate engagement of multidisciplinary medical teams, centralize external toxicity management insights to identify key evidence and educational gaps, deliver clinically relevant and impactful medical education tailored to provider segments, and drive the coordinated development of applicable scientific narratives across oncology assets. 

Responsibilities

• Ensures medical affairs launch planning includes robust considerations for expected adverse reactions and their management, including considerations for multidisciplinary care pathways, portfolio, and global perspectives.
• Initiates medical affairs activities to improve health care professional understanding of toxicity detection and mitigation strategies across the oncology therapeutic area (TA) to serve both US and International markets for key indications/ brands.
• Partners with relevant cross-functional R&D partners, in